Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

ClinicalTrials.gov ID: NCT01427296

Public ClinicalTrials.gov record NCT01427296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Randomized, Active Comparator, Open-Label, Multicenter Study to Assess the Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.

Study identification

NCT ID
NCT01427296
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
2,154 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 16, 2011 (Actual)
Primary completion
Mar 11, 2014 (Actual)
Completion
Dec 9, 2014 (Actual)
Last update posted
Jan 18, 2018

2011 – 2014

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
18
Facility City State ZIP Site status
Not listed San Carlos California — —
Not listed Bristol Connecticut — —
Not listed Macon Georgia — —
Not listed Suwanee Georgia — —
Not listed Hagerstown Maryland — —
Not listed Wyoming Michigan — —
Not listed Mexico Missouri — —
Not listed Vineland New Jersey — —
Not listed Great Neck New York — —
Not listed New York New York — —
Not listed Fayetteville North Carolina — —
Not listed High Point North Carolina — —
Not listed Raleigh North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Mentor Ohio — —
Not listed Plano Texas — —
Not listed Chesapeake Virginia — —
Not listed Bellevue Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01427296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01427296 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →